BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression

  The positive results support the company’s planned regulatory submissions.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  What a Turnaround: Otonomy Explodes as Lead Drug Succeeds in Late-Stage Study

  The company plans to meet with FDA to discuss results and clinical requirements for registration.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Recipharm to End Operations at Two Swedish Facilities, 225 Employees Affected

  The company will explore opportunity to close facilities during second half of 2019.

  November 9, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  GlaxoSmithKline Poaches New CSO From Google’s Calico

  Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech.

  November 9, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  After $40M Financing, Exonics Therapeutics to Start Hiring for Cambridge Lab

  The cash will allow the company to hire scientists to conduct preclinical research into a potential treatment for DMD.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• Drug Development

  Anthera Pharmaceuticals Announces Completion of Recruitment in the Phase III RESULT Clinical Study of Sollpura

  The RESULT study allows for more frequent and higher dose adjustments based upon clinical signs and symptoms than the previous Phase 3 SOLUTION study.

  November 9, 2017

   · 

  2 min read
• 

  Business

  GlaxoSmithKline’s Pain in China is AstraZeneca’s Gain

  China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales.

  November 9, 2017

   · 

  1 min read
• 

  Business

  IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes

  ImmunoMolecular Therapeputics officially launched yesterday.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Siemens to Replace Healthineers CFO in Preparation for Listing

  The public listing is expected to value the business at around $46 billion.

  November 9, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Sangamo Inks Deal for New HQ in Bay Area Biotech Hub

  Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry